Horizon Pharma Inc (NASDAQ: HZNP) biopharmaceutical company developer of innovative medicines announced pricing of its underwritten public offering of 21.4 million units of common stocks, priced at $3.50 each. The units consist of common stock and a warrant to purchase 0.5 of a share of common stock.
The warrants and shares of common stock are separable straightway and also these will be separately issued.
The warrants will expire after five years from the date of issuance and exercisable at $4.57 each.
Horizon Pharma Inc (NASDAQ:HZNP) trade with volume of 7,166,300 shares in last session was unexpectedly higher versus average trading capacity of 787,966.00 shares. The stock at opening bell was at $3.41gained the maximum price level of $3.54 and then finished the day at $3.48 by scoring -24.02%.
HZNP remained successful in generating revenue of 10.16 million in the trailing twelve months and made net income of -$140.47 million. The Company maintained a negative -1382.12%for the net profit margin and in its operating margin it had -1407.42%.
The HZNP painted price to sales ratio of 11.57 and price to cash ratio at 1.85 for past 12 months. As far as the returns from the company is concern, return on asset remained as -87.48%.
The stock showed downbeat performance of -25.32% for the week which for the last 21 trading days was maintained at -14.91%. Likewise the negative performance for the trailing 3 months was recorded as -30.26% and in last 252 trading days which equals to a year was -56.61% while the performance so far in current year remained at -13.00%.
Fast Moving Stock does not own any shares or plan to get a position(s) in the company(s) anytime soon. Moreover, we have not been compensated for the posting of this article/report/analysis, as this is just an opinion of our writer/contributor. Not recommandation to buy or sell any stocks Read full